| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 12 | 2025 | 460 | 3.610 |
Why?
|
| Lymphocytic Choriomeningitis | 6 | 2022 | 12 | 1.810 |
Why?
|
| Receptors, Glucocorticoid | 5 | 2018 | 105 | 1.550 |
Why?
|
| Programmed Cell Death 1 Receptor | 7 | 2025 | 140 | 1.530 |
Why?
|
| RNA, Long Noncoding | 4 | 2022 | 230 | 1.340 |
Why?
|
| Response Elements | 5 | 2018 | 99 | 1.270 |
Why?
|
| DNA | 5 | 2017 | 1442 | 1.190 |
Why?
|
| Lymphocytic choriomeningitis virus | 5 | 2022 | 15 | 1.030 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2022 | 199 | 0.880 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1297 | 0.790 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 327 | 0.780 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 4 | 2025 | 140 | 0.700 |
Why?
|
| Tumor Microenvironment | 6 | 2025 | 704 | 0.600 |
Why?
|
| Transcriptome | 4 | 2022 | 1162 | 0.590 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 1788 | 0.580 |
Why?
|
| Head and Neck Neoplasms | 4 | 2025 | 631 | 0.570 |
Why?
|
| Conserved Sequence | 2 | 2019 | 281 | 0.560 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2015 | 17 | 0.560 |
Why?
|
| Antigens, CD | 1 | 2019 | 418 | 0.540 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1541 | 0.500 |
Why?
|
| Cell Differentiation | 4 | 2023 | 1944 | 0.490 |
Why?
|
| Neoplasms | 5 | 2022 | 2969 | 0.480 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2025 | 131 | 0.480 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 1397 | 0.480 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2016 | 624 | 0.470 |
Why?
|
| NF-kappa B | 1 | 2018 | 448 | 0.470 |
Why?
|
| RNA, Small Nucleolar | 1 | 2014 | 16 | 0.440 |
Why?
|
| Antibodies, Viral | 5 | 2022 | 1169 | 0.440 |
Why?
|
| Apoptosis | 2 | 2025 | 1861 | 0.410 |
Why?
|
| Receptors, Steroid | 1 | 2014 | 172 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4762 | 0.380 |
Why?
|
| Mice | 17 | 2025 | 18470 | 0.350 |
Why?
|
| Animals | 23 | 2025 | 34335 | 0.350 |
Why?
|
| Immunologic Memory | 4 | 2022 | 202 | 0.350 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 657 | 0.340 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 549 | 0.330 |
Why?
|
| Glucocorticoids | 1 | 2012 | 350 | 0.320 |
Why?
|
| Antibodies, Neutralizing | 4 | 2022 | 517 | 0.320 |
Why?
|
| HeLa Cells | 3 | 2018 | 694 | 0.320 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 1956 | 0.300 |
Why?
|
| Humans | 32 | 2025 | 131501 | 0.290 |
Why?
|
| Protein Binding | 5 | 2017 | 1710 | 0.280 |
Why?
|
| Crystallography, X-Ray | 4 | 2018 | 365 | 0.280 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2462 | 0.270 |
Why?
|
| Plasma Cells | 2 | 2025 | 55 | 0.260 |
Why?
|
| Binding Sites | 4 | 2021 | 1202 | 0.250 |
Why?
|
| Cytokines | 1 | 2012 | 1346 | 0.250 |
Why?
|
| Gene Expression Regulation | 5 | 2022 | 2355 | 0.250 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 3 | 2023 | 14 | 0.250 |
Why?
|
| Transcription Factors | 1 | 2015 | 2436 | 0.240 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 410 | 0.230 |
Why?
|
| Dengue Virus | 2 | 2017 | 134 | 0.230 |
Why?
|
| Protein Structure, Tertiary | 3 | 2017 | 723 | 0.230 |
Why?
|
| Cell Line, Tumor | 7 | 2025 | 3672 | 0.230 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 59 | 0.230 |
Why?
|
| Amino Acid Sequence | 5 | 2016 | 2562 | 0.220 |
Why?
|
| Zika Virus | 2 | 2017 | 155 | 0.220 |
Why?
|
| Models, Molecular | 3 | 2018 | 1087 | 0.220 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2025 | 93 | 0.210 |
Why?
|
| Base Sequence | 4 | 2017 | 2782 | 0.210 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 80 | 0.210 |
Why?
|
| Cisplatin | 1 | 2025 | 286 | 0.210 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2019 | 22 | 0.200 |
Why?
|
| Molecular Sequence Data | 4 | 2016 | 3614 | 0.200 |
Why?
|
| Antigens, Neoplasm | 1 | 2025 | 405 | 0.180 |
Why?
|
| Clone Cells | 1 | 2022 | 171 | 0.180 |
Why?
|
| Interleukin-2 | 1 | 2022 | 238 | 0.180 |
Why?
|
| Allergy and Immunology | 1 | 2021 | 31 | 0.170 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 76 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2025 | 676 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 825 | 0.160 |
Why?
|
| Immunotherapy | 2 | 2023 | 765 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2023 | 285 | 0.160 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2019 | 13 | 0.160 |
Why?
|
| Lymphoid Tissue | 1 | 2020 | 48 | 0.160 |
Why?
|
| Granzymes | 1 | 2019 | 47 | 0.160 |
Why?
|
| Cross Reactions | 2 | 2017 | 187 | 0.150 |
Why?
|
| Papillomaviridae | 1 | 2020 | 179 | 0.150 |
Why?
|
| Viral Envelope Proteins | 2 | 2017 | 157 | 0.150 |
Why?
|
| Mutation | 5 | 2022 | 6176 | 0.150 |
Why?
|
| Synteny | 1 | 2019 | 69 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2025 | 4674 | 0.150 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 106 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2012 | 329 | 0.140 |
Why?
|
| Datasets as Topic | 1 | 2019 | 102 | 0.140 |
Why?
|
| Genes, Retinoblastoma | 1 | 2018 | 22 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2018 | 809 | 0.140 |
Why?
|
| Dengue | 2 | 2017 | 123 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 502 | 0.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 43 | 0.140 |
Why?
|
| Nucleic Acids | 1 | 2018 | 26 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 529 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 300 | 0.130 |
Why?
|
| Retinoblastoma | 1 | 2018 | 87 | 0.130 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 74 | 0.130 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 112 | 0.130 |
Why?
|
| Interferon-gamma | 1 | 2019 | 542 | 0.130 |
Why?
|
| Protein Structure, Secondary | 2 | 2014 | 238 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 211 | 0.130 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 680 | 0.120 |
Why?
|
| Saccharomyces | 1 | 2016 | 9 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4683 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2016 | 88 | 0.120 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 61 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 420 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2014 | 595 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2016 | 266 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 642 | 0.120 |
Why?
|
| Immune System | 1 | 2016 | 98 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 556 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2025 | 1988 | 0.110 |
Why?
|
| Substrate Specificity | 1 | 2015 | 286 | 0.110 |
Why?
|
| Pseudohypoaldosteronism | 1 | 2014 | 1 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1831 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 634 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 1217 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2018 | 292 | 0.110 |
Why?
|
| Stem Cells | 1 | 2019 | 712 | 0.110 |
Why?
|
| Structural Homology, Protein | 1 | 2014 | 27 | 0.110 |
Why?
|
| Binding, Competitive | 1 | 2014 | 152 | 0.110 |
Why?
|
| Telomere Homeostasis | 1 | 2014 | 47 | 0.110 |
Why?
|
| Lipids | 1 | 2018 | 565 | 0.110 |
Why?
|
| Songbirds | 1 | 2014 | 8 | 0.110 |
Why?
|
| Gene Expression | 2 | 2018 | 1500 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2014 | 230 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 283 | 0.100 |
Why?
|
| Probiotics | 1 | 2016 | 231 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2014 | 420 | 0.100 |
Why?
|
| Female | 11 | 2025 | 71086 | 0.090 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 36 | 0.090 |
Why?
|
| Cell Line | 2 | 2018 | 2603 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 148 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 1001 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2014 | 500 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2012 | 152 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2014 | 751 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 579 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1313 | 0.080 |
Why?
|
| Brain | 1 | 2023 | 3237 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2014 | 510 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 794 | 0.080 |
Why?
|
| Microbiota | 1 | 2016 | 441 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 434 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3403 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 2646 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1490 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2014 | 984 | 0.070 |
Why?
|
| Neutralization Tests | 2 | 2021 | 226 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 470 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 894 | 0.070 |
Why?
|
| Chromatin | 2 | 2022 | 491 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 722 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1417 | 0.060 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2025 | 35 | 0.060 |
Why?
|
| Smoke | 1 | 2025 | 66 | 0.060 |
Why?
|
| Male | 4 | 2019 | 65158 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2025 | 344 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 127 | 0.050 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2022 | 27 | 0.050 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2022 | 5 | 0.050 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2022 | 14 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2022 | 6 | 0.050 |
Why?
|
| CD28 Antigens | 1 | 2022 | 75 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 69 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2022 | 116 | 0.050 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 53 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 119 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 357 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 258 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 20 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 37 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 432 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 97 | 0.040 |
Why?
|
| Epigenomics | 1 | 2022 | 186 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 427 | 0.040 |
Why?
|
| Receptors, CXCR5 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 804 | 0.040 |
Why?
|
| Cell Separation | 1 | 2020 | 221 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 359 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 123 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2022 | 317 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2019 | 118 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2363 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 57 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 463 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2019 | 63 | 0.040 |
Why?
|
| Leadership | 1 | 2021 | 241 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 4515 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 1168 | 0.040 |
Why?
|
| Anaplasia | 1 | 2018 | 7 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 381 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2018 | 50 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 275 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 810 | 0.030 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2017 | 7 | 0.030 |
Why?
|
| Cross Protection | 1 | 2017 | 10 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2017 | 20 | 0.030 |
Why?
|
| South America | 1 | 2017 | 45 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1040 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 180 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 368 | 0.030 |
Why?
|
| Culicidae | 1 | 2017 | 69 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2018 | 605 | 0.030 |
Why?
|
| Vero Cells | 1 | 2016 | 114 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 389 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 237 | 0.030 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 178 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 758 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1008 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 749 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 535 | 0.030 |
Why?
|
| Monocytes | 1 | 2016 | 337 | 0.030 |
Why?
|
| Animal Communication | 1 | 2014 | 4 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 530 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 769 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 666 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1236 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2205 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2014 | 229 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 32 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2969 | 0.020 |
Why?
|
| Haplotypes | 1 | 2014 | 543 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 127 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2012 | 150 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 934 | 0.020 |
Why?
|
| Aromatase | 1 | 2010 | 23 | 0.020 |
Why?
|
| Gene Order | 1 | 2010 | 82 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 89 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 249 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2567 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 886 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 10952 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13300 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15047 | 0.010 |
Why?
|